[The clinical efficacy of tanakan in patients with stage-I atherosclerotic circulatory encephalopathy].
Rudenko
A E
AE
Lushchik
U B
UB
Dzhumik
V A
VA
D004341:Drug Evaluation; D005419:Flavonoids / Q000627:therapeutic use*; D020441:Ginkgo biloba; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D008570:Memory, Short-Term / Q000187:drug effects; D008875:Middle Aged; D010936:Plant Extracts; D013997:Time Factors; D000096983:Ginkgo Extract
D005419:Flavonoids; D010936:Plant Extracts; C063170:Ginkgo biloba extract; D000096983:Ginkgo Extract